Aljada A - Search Results

1

Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.

Aljada A, Dong L, Mousa SA. Aljada A, et al. Curr Opin Investig Drugs. 2010 Oct;11(10):1158-68. Curr Opin Investig Drugs. 2010. PMID: 20872319 Review.

2

PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.

Aljada A, O'Connor L, Fu YY, Mousa SA. Aljada A, et al. Angiogenesis. 2008;11(4):361-7. doi: 10.1007/s10456-008-9118-0. Epub 2008 Sep 23. Angiogenesis. 2008. PMID: 18810647

3

Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?

Aljada A, Shah KA, Mousa SA. Aljada A, et al. PPAR Res. 2009;2009:460764. doi: 10.1155/2009/460764. Epub 2009 Aug 19. PPAR Res. 2009. PMID: 19696948 Free PMC article.

4

Metformin and neoplasia: implications and indications.

Aljada A, Mousa SA. Aljada A, et al. Pharmacol Ther. 2012 Jan;133(1):108-15. doi: 10.1016/j.pharmthera.2011.09.004. Epub 2011 Sep 6. Pharmacol Ther. 2012. PMID: 21924289 Review.

5

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.

Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ. Mousa SA, et al. Among authors: aljada a. Angiogenesis. 2008;11(2):183-90. doi: 10.1007/s10456-007-9088-7. Epub 2007 Dec 13. Angiogenesis. 2008. PMID: 18080776

6

Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.

Mousa SA, Zhang F, Aljada A, Chaturvedi S, Takieddin M, Zhang H, Chi L, Castelli MC, Friedman K, Goldberg MM, Linhardt RJ. Mousa SA, et al. Among authors: aljada a. J Clin Pharmacol. 2007 Dec;47(12):1508-20. doi: 10.1177/0091270007307242. J Clin Pharmacol. 2007. PMID: 18048572 Free PMC article. Clinical Trial.

7

Calcium, calmodulin and protein kinase C dependence of platelet shape change.

Dandona P, Thusu K, Khurana U, Love J, Aljada A, Mousa S. Dandona P, et al. Among authors: aljada a. Thromb Res. 1996 Jan 15;81(2):163-75. doi: 10.1016/0049-3848(95)00233-2. Thromb Res. 1996. PMID: 8822131

8

Heparin inhibits reactive oxygen species generation by polymorphonuclear and mononuclear leucocytes.

Dandona P, Qutob T, Hamouda W, Bakri F, Aljada A, Kumbkarni Y. Dandona P, et al. Among authors: aljada a. Thromb Res. 1999 Dec 15;96(6):437-43. doi: 10.1016/s0049-3848(99)00132-2. Thromb Res. 1999. PMID: 10632466 Clinical Trial.

9

Effect of insulin on human aortic endothelial nitric oxide synthase.

Aljada A, Dandona P. Aljada A, et al. Metabolism. 2000 Feb;49(2):147-50. doi: 10.1016/s0026-0495(00)91039-4. Metabolism. 2000. PMID: 10690935

10

A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis.

Dandona P, Aljada A. Dandona P, et al. Among authors: aljada a. Am J Cardiol. 2002 Sep 5;90(5A):27G-33G. doi: 10.1016/s0002-9149(02)02556-0. Am J Cardiol. 2002. PMID: 12231076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters